There is a significant short in CTIX and that is why it is drawing so much attention from those that own no shares. They also know that their bi-monthly reports are worthless. Actually, the daily reports while not 100% accurate are far more accurate when compared to the bi monthly reports. They are fairly accurate (with the exception of T trades) on the dailys in an effort to avoid the good sized fines and negative publicity that was handed out a couple of years ago to Credit Suisse, Merrill Lynch, etc.. and the bi monthly provides plenty of time for them to hide their dirty work in ex-clearing, etc.. The shorts are protected by the regulators sadly and the regulators point blank tell CEO's not to do anything that would cause a short squeeze lest they be charged with manipulation. Crazy doings. Is it any wonder the regulators when they leave end up getting big jobs with those they formally regulated? The best news is they have no control over the science and if the science is good enough there will be a bust out. That is what I expect to happen with CTIX. Cover story on the New England Journal of Medicine or some such might be just the ticket.
Go CTIX!!!